Logo

American Heart Association

  16
  0


Final ID: MP481

Coronary Artery Calcium Predicts All-cause and Non-coronary Mortality

Abstract Body (Do not enter title and authors here): Background: Coronary artery calcium (CAC) is a strong predictor of coronary artery disease (CAD) risk, and CAC=0 is a highly favorable prognostic marker. Recently, the prognostic value of CAC has been proposed to extend to all-cause and non-coronary mortality. For example, CAC is a predictor of calcification in other vascular beds, and CAD is reported to impact immune surveillance and cancer risk.
Methods: We tested whether CAC can predict the risk of total mortality (TM), and we estimated whether cause-specific and non-coronary mortality distributions are impacted by CAC. We searched the Intermountain Health electronic medical records (eMR) database for patients (pts) at primary coronary risk who underwent positron emission tomography/computed tomography (PET/CT) stress testing and had a 5y follow-up. We compared unadjusted and age/sex-adjusted TM rates between CAC=0 and CAC>0 pts. We determined cause-specific mortality proportions for all CAC=0 pts and estimated these from a 1:10 random sample of CAC>0 pts by chart review. We examined proportions of 5y cause-specific deaths in CAC=0 pts and explored differences with CAC>0 patients.
Results: The eMR search identified 40,018 pts undergoing PET/CT who were at primary coronary risk. Mean age was 65.8 [11.9] y; 48.7% were female; 7967 (19.9%) had CAC=0 by CT; and 32,051 were CAC>0. There were 238 deaths (2.99%) in CAC=0 and 2834 (8.84%) in CAC>0 cohort, for a relative risk (RR) of 0.34 (p<0.001). In age and sex adjusted logistic regression, CAC>0 remained a highly significant risk factor (OR=2.04, p<0.0001; Table 1). Distributions of cause-specific deaths are shown in Table 2 by CAC category. CAC=0 predicted a very low proportion of CAD-related and total cardiovascular (CV) deaths. Most of the greater rate of TM in CAC>0 patients was estimated to be non-CV.
Conclusions:
In this large, integrated healthcare system experience, a zero CAC score predicted an excellent prognosis for TM, with CAC>0 being associated with a >2-fold greater TM risk than CAC=0. Further, CAC=0 was associated with a very low proportion of both CAD-related and all CV mortality. Most of CAC>0 TM was estimated to be non-CV. The implications of a zero CAC score may go beyond simply marking a low risk of CAD-related events to also being a marker of general vascular health and improved overall survival.
  • Anderson, Jeffrey  ( INTERMOUNTAIN MEDICAL CENTER , Murray , Utah , United States )
  • Collingridge, Dave  ( INTERMOUNTAIN MEDICAL CENTER , Murray , Utah , United States )
  • Knight, Stacey  ( INTERMOUNTAIN MEDICAL CENTER , Murray , Utah , United States )
  • Le, Viet  ( INTERMOUNTAIN MEDICAL CENTER , Murray , Utah , United States )
  • Iverson, Leslie  ( INTERMOUNTAIN MEDICAL CENTER , Murray , Utah , United States )
  • Bair, Tami  ( Intermountain Medical Center , Salt Lake Cty , Utah , United States )
  • Mason, Steve  ( Intermountain Medical Center , Salt Lake Cty , Utah , United States )
  • Muhlestein, Joseph  ( Intermountain Medical Center , Salt Lake Cty , Utah , United States )
  • Knowlton, Kirk  ( Intermountain Medical Center , Salt Lake Cty , Utah , United States )
  • Author Disclosures:
    Jeffrey Anderson: DO NOT have relevant financial relationships | Dave Collingridge: No Answer | Stacey Knight: DO NOT have relevant financial relationships | Viet Le: DO have relevant financial relationships ; Researcher:Janssen/J&J:Active (exists now) ; Advisor:Pfizer:Active (exists now) ; Advisor:Amgen:Active (exists now) ; Advisor:Bayer:Active (exists now) ; Advisor:Novartis:Active (exists now) ; Advisor:Idorsia:Active (exists now) ; Advisor:Lexicon:Active (exists now) ; Research Funding (PI or named investigator):Kardia:Active (exists now) | Leslie Iverson: DO NOT have relevant financial relationships | Tami Bair: DO NOT have relevant financial relationships | Steve Mason: No Answer | Joseph Muhlestein: DO NOT have relevant financial relationships | Kirk Knowlton: DO have relevant financial relationships ; Research Funding (PI or named investigator):novartis:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Cracking the Code of Coronary Care: Timing, Trials, and Turning Points in Acute MI Management

Saturday, 11/08/2025 , 10:45AM - 11:55AM

Moderated Digital Poster Session

More abstracts on this topic:
More abstracts from these authors:
Does the Prognostic Value of Zero Coronary Artery Calcium Score Vary by Patient Sex?

Anderson Jeffrey, Horne Benjamin, Collingridge Dave, Le Viet, Iverson Leslie, Muhlestein Joseph, Bair Tami, Knight Stacey, Mason Steve, Knowlton Kirk

Lipoprotein (a) [Lp(a)] levels are not associated with MACE outcomes in patients with suspected CAD referred for Cardiac PET/CT stress tests in an integrated health system

Le Viet, Knight Stacey, Muhlestein Joseph, May Heidi, Iverson Leslie, Bair Tami, Knowlton Kirk, Anderson Jeffrey

You have to be authorized to contact abstract author. Please, Login
Not Available